Comparative study of pirlindole, a selective RIMA, and its two enantiomers using biochemical and behavioural techniques

被引:7
作者
Bruhwyler, J
Liégeois, JF
Gérardy, J
Damas, J
Chleide, E
Lejeune, C
Decamp, E
de Tullio, P
Delarge, J
Dresse, A
Géczy, J
机构
[1] Therabel Res SA, B-1180 Brussels, Belgium
[2] Univ Liege, Inst Pharm, Liege, Belgium
[3] Univ Liege, Inst Physiol, Liege, Belgium
[4] Univ Liege, Pharmacol Lab, Liege, Belgium
[5] ClinTrials Res Ltd, Zaventem, Belgium
[6] Univ Namur, Fac Med, Namur, Belgium
来源
BEHAVIOURAL PHARMACOLOGY | 1998年 / 9卷 / 08期
关键词
antidepressant; behavioural models; biochemistry; enantiomer; mouse; pirlindole; rat; reversible inhibitors of monoamine oxidase A;
D O I
10.1097/00008877-199812000-00008
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The interaction with monoamine oxidase A (MAO-A) and B has been shown to be sensitive to the absolute configuration of molecules. Therefore, the aim of this study was to compare the effects of the racemic pirlindole (a selective and reversible MAO-A inhibitor) and its two enantiomers using biochemical techniques (in vitro and ex vivo determination of rat brain MAO-A and MAO-B activity) and behavioural models (forced swimming test and reserpine-induced hypothermia and palpebral ptosis test). In vitro, the MAO-A IC50 of (+/-)-pirlindole, R-(-)-pirlindole and S-(+)-pirlindole were 0.24, 0.43 and 0.18 mu M, respectively. Ex vivo, their ID50 were 24.4, 37.8 and 18.7 mg/kg i.p. The differences between the three compounds were not significant, with a ratio between the two enantiomers [R-(-)/S-(+)] of 2.2 in vitro and 2.0 ex vivo. MAO-B was only slightly inhibited. In the forced swimming test and the reserpine-induced hypothermia and ptosis model, the three compounds had an antidepressant profile. In the forced swimming test, the minimal effective dose ratio between the R-(-) and the S-(+) was again around 2.0. The behavioural observations were thus clearly in accordance,vith the biochemical data. Behav Pharmacol 1998; 9:731-737 (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:731 / 737
页数:7
相关论文
共 24 条
[1]  
Barker Eric L., 1995, P321
[2]   ADVERSE-EFFECTS OF ANTI-DEPRESSANT DRUGS .1. MONOAMINE-OXIDASE INHIBITORS AND TRICYCLICS [J].
BLACKWELL, B .
DRUGS, 1981, 21 (03) :201-219
[3]  
Bruhwyler J, 1995, BEHAV PHARMACOL, V6, P830
[4]   Pirlindole: A selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties [J].
Bruhwyler, J ;
Liegeois, JF ;
Geczy, J .
PHARMACOLOGICAL RESEARCH, 1997, 36 (01) :23-33
[5]  
BRUHWYLER J, 1997, EUR J CLIN RES, V9, P225
[6]  
BURKARD WP, 1989, J PHARMACOL EXP THER, V248, P391
[7]  
DAPRADA M, 1989, J PHARMACOL EXP THER, V248, P400
[8]   First preparative enantiomer resolution of pirlindole, a potent antidepressant drug [J].
de Tullio, P ;
Felikidis, A ;
Pirotte, B ;
Liégeois, JF ;
Stachow, M ;
Delarge, J ;
Ceccato, A ;
Hubert, P ;
Crommen, J ;
Géczy, J .
HELVETICA CHIMICA ACTA, 1998, 81 (03) :539-547
[9]   A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression [J].
DeWilde, JE ;
Geerts, S ;
VanDorpe, J ;
Bruhwyler, J ;
Geczy, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (06) :404-410
[10]   DIFFERENT STEREOSELECTIVE INHIBITION OF MONOAMINE OXIDASE-B BY THE R-ENANTIOMERS AND S-ENANTIOMERS OF MD-780236 [J].
DOSTERT, P ;
BENEDETTI, MS ;
GUFFROY, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (03) :161-165